23 - 24 February, 2010, Mövenpick Hotel Amsterdam City Centre, Amsterdam, The Netherlands
Register by 115th January 2010 and receive up to €150 off!
Download the Brochure
Free downloads available! Access our Download Centre
Become a Pharma IQ Member and receive our weekly newsletter!
Learn more about sponsor & exhibit opportunities
Countdown to Event
Mark Your Calendar
Tell a Colleague
The lucrative nature of the pharmaceutical counterfeiting industry, means that regrettably this is a big business and one that is continuing to grow. With a recent report from the European Commission stating seizures rose to 49,000 cases of infringing goods intercepted at the EU's external border in 2008, compared to 43,000 in 2007.*
*http://ec.europa.eu
These statistics coupled with the WHO report estimating the global value of trade in counterfeit pharmaceuticals is between US$32 and 46 billion, in addition to the European Mandate coming to fruition in February means that this is a particularly pertinent issue that Pharmaceutical Companies are looking to address now.
The issues above barely touch the surface, when we look more deeply at the pharmaceutical anti-counterfeiting industry further problems arise
From Pharmaceutical Companies
Non in house pharmaceutical Representatives
Giving you an exceptional opportunity to network and benchmark your internal processes, as well as understand the thought process, developments and timelines that other organisations decisions may have on your internal business.
[ Register Now ]